The effects of resistance exercise on physical performance and health-related quality of life in prostate cancer patients: a systematic review

Supportive Care in Cancer

Volumn 23, Issue 8, 2015, Pages 2479-2497

  Hasenoehrl, T ^a   Keilani, M ^a   Sedghi Komanadj, T ^a   Mickel, M ^a   Margreiter, M ^a   Marhold, M ^a   Crevenna, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Androgen deprivation therapy; Muscular strength; Physical performance; Prostate cancer; Quality of life; Resistance exercise

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; TRIACYLGLYCEROL;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BODY COMPOSITION; BONE DENSITY; CANCER FATIGUE; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR PERFORMANCE; ENDURANCE TRAINING; HUMAN; LIPID BLOOD LEVEL; MALE; MUSCLE EXERCISE; MUSCLE MASS; MUSCLE STRENGTH; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RESISTANCE TRAINING; STRETCHING EXERCISE; SYSTEMATIC REVIEW; EXERCISE; KINESIOTHERAPY; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RISK FACTOR;

BODY COMPOSITION; EXERCISE; EXERCISE THERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RISK FACTORS;

EID: 84933181714     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2782-x     Document Type: Article

References (62)

1. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvão DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, Schneider CM, von Gruenigen VE, Schwartz AL (2010) American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409–1426. doi:10.1249/MSS.0b013e3181e0c112
2. Harrison MR, Jones LW (2014) Exercise as treatment for androgen deprivation therapy-associated physical dysfunction: ready for prime time? Eur Urol 65:873–874. doi:10.1016/j.eururo.2013.11.033
3. Cormie P, Newton RU, Taaffe DR, Spry N, Galvão DA (2013) Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol 10:731–736. doi:10.1038/nrurol.2013.206
4. Gardner JR, Livingston PM, Fraser SF (2014) Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol 32:335–346. doi:10.1200/JCO.2013.49.5523
5. Ahmadi H, Daneshmand S (2013) Androgen deprivation therapy: evidence-based management of side effects. BJU Int 111:543–548. doi:10.1111/j.1464-410X.2012.11774.x
6. Galvão DA, Spry N, Taaffe DR, Newton RU, Stanley J, Shannon T, Rowling C, Prince R (2008) Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int 102:44–47. doi:10.1111/j.1464-410X.2008.07539.x
7. Galvão DA, Taaffe DR, Spry N, Joseph D, Turner D, Newton RU (2009) Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation. Prostate Cancer Prostatic Dis 12:198–203. doi:10.1038/pcan.2008.51
8. Smith MR, Lee H, Fallon MA, Nathan DM (2008) Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology 71:318–322. doi:10.1016/j.urology.2007.08.035
9. Braga-Basaria M, Muller DC, Carducci MA, Dobs AS, Basaria S (2006) Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy. Int J Impot Res 18:494–498
10. Dockery F, Bulpitt CJ, Agarwal S, Donaldson M, Rajkumar C (2003) Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci (Lond) 104:195–201
11. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU (2009) Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure. Prostate Cancer Prostatic Dis 12:233–240. doi:10.1038/pcan.2009.12
12. Collier A, Gosh S, McGlynn B, Hollins G (2012) Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes and cardiovascular disease. Am J Clin Oncol 35:504–509
13. Shahinian VB, Kou YF, Freeman JL, Goodwin JS (2005) Risk of fracture after androgen deprivation for prostate cancer. New Engl J Med 352:154–164
14. Chipperfield K, Fletcher J, Millar J, Brooker J, Smith R, Frydenberg M, Burney S (2013) Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy. Psychoncology 22:2169–2176. doi:10.1002/pon.3269
15. Benedict C, Traeger L, Dahn JR, Antoni M, Zhou ES, Bustillo N, Penedo FJ (2014) Sexual bother in men with advanced prostate cancer undergoing androgen deprivation therapy. J Sex Med 11:2571–2580. doi:10.1111/jsm.12645
16. Beydoun N, Bucci JA, Chin YS, Spry N, Newton RU, Galvao DA (2014) Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy. J Med Imaging Radiat Oncol 58:369–376. doi:10.1111/1754-9485.12115
17. Galvão DA, Taaffe DR, Spry N, Newton RU (2007) Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis 10:340–346
18. Hvid T, Winding K, Rinnov A, Dejgaard T, Thomsen C, Iversen P, Brasso K, Mikines KJ, van Hall G, Lindegaard B, Solomon TPJ, Pedersen BK (2013) Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy. Endocr Relat Cancer 20:621–632. doi:10.1530/ERC-12-0393
19. Keogh JWL, MacLeod RD (2012) Body composition, physical fitness, functional performance, quality of life and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manag 43:96–110. doi:10.1016/j.jpainsymman.2011.03.006
20. Larkin D, Lopez V, Aromataris E (2013) Managing cancer-related fatigue in men with prostate cancer: a systematic review of non-pharmacological interventions. Int J Nurs Pract NOV. doi:10.1111/ijn.12211
21. Parsons JK (2014) Prostate cancer and the therapeutic benefits of structured exercise. J Clin Oncol 32:271–272. doi:10.1200/JCO.2013.53.4289
22. Galvao DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, Suzuki K, Yamaya K, Newton RU (2006) Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 38:2045–2052
23. Galvao DA, Nosaka K, Taaffe DR, Peake J, Spry N, Suzuki K, Yamaya K, McGuigan MR, Kristjanson LJ, Newton RU (2008) Endocrine and immune responses to resistance training in prostate cancer patients. Prostate Cancer Prostatic Dis 11:160–165
24. Hanson ED, Sheaff AK, Sood S, Ma L, Francis JD, Goldberg AP, Hurley BF (2013) Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy. J Gerontol A Biol Sci Med Sci 68:490–498. doi:10.1093/gerona/gls206
25. Santa Mina D, Alibhai SMH, Matthew AG, Guglietti CL, Pirbaglou M, Trachtenberg J, Ritvo P (2013) A randomized trial of aerobic versus resistance exercise in prostate cancer survivors. J Aging Phys Act 21:455–478
26. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, Slovinec D’Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21:1653–1659
27. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud’Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D’Angelo ME (2009) Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 27:344–351. doi:10.1200/JCO.2007.15.4963
28. Bourke L, Doll H, Crank H, Daley A, Rosario D, Saxton JM (2011) Lifestyle intervention in men with advanced prostate cancer receiving androgen suppression therapy: a feasibility study. Cancer Epidemiol Biomarkers Prev 20:647–657. doi:10.1158/1055-9965.EPI-10-1143
29. Bourke L, Gilbert S, Hooper R, Steed LA, Joshi M, Catto JW, Saxton JM, Rosario DJ (2014) Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 65:865–872. doi:10.1016/j.eururo.2013.09.040
30. Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA (2013) Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis 16:328–335. doi:10.1038/pcan.2013.22
31. Cormie P, Galvao DA, Spry N, Joseph D, Chee R, Taaffe DR, Chambers SK, Newton RU (2014) Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomized controlled trial. BJU Int. doi:10.1111/bju.12646
32. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU (2010) Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28:340–347. doi:10.1200/JCO.2009.23.2488
33. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU (2011) Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response. J Urol 186:1291–1297. doi:10.1016/j.juro.2011.05.055
34. Galvao DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, Lamb DS, Chambers SK, Newton RU (2014) A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 65:856–864. doi:10.1016/j.eururo.2013.09.041
35. Park SW, Kim TN, Nam JK, Ha HK, Shin DG, Lee W, Kim MS, Chung MK (2012) Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled study. Urology 80:299–306. doi:10.1016/j.urology.2011.12.060
36. Winters-Stone KM, Dobek JC, Bennett JA, Maddalozzo JF, Ryan CW, Beer TM (2014) Skeletal response to resistance and impact training in prostate cancer survivors. Med Sci Sports Exerc 46:1482–1488. doi:10.1249/MSS.0000000000000265
37. Buffart LM, Galvao DA, Chinapaw MJ, Brug J, Taaffe DR, Spry N, Joseph D, Newton RU (2014) Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer. Cancer 120:294–301. doi:10.1002/cncr.28396
38. Courneya KS, Segal RJ, Reid RD, Jones LW, Malone SC, Venner PM, Parliament MB, Scott CG, Quinney HA, Wells GA (2004) Three independent factors predicted adherence in a randomized controlled trial of resistance exercise training among prostate cancer survivors. J Clin Epidemiol 57:571–579
39. Alberga AS, Segal RJ, Reid RD, Scott CG, Sigal RJ, Khandwala F, Jaffey J, Wells GA, Kenny GP (2012) Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer. Support Care Cancer 20:971–981. doi:10.1007/s00520-011-1169-x
40. Cormie P, Newton RU, Taaffe DR, Spry N, Joseph D, Akhlil Hamid M, Galvao DA (2013) Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis 16:170–175. doi:10.1038/pcan.2012.52
41. Mina DS, Connor MK, Alibhai SMH, Toren P, Guglietti C, Matthew AG, Trachtenberg J, Ritvo P (2013) Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: a randomized study. Can Urol Assoc J 7:E692–698. doi:10.5489/cuaj.235
42. Winters-Stone KM, Dobek JC, Bennett JA, Dieckmann NF, Maddalozzo GF, Ryan CW, Beer TM (2014) Resistance training reduces disability in prostate cancer survivors on androgen deprivation therapy: evidence from a randomized controlled trial. Arch Phys Med Rehabil. doi:10.1016/j.apmr.2014.08.010
43. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377–384
44. Prentice AM, Jebb SA (2001) Beyond body mass index. Obes Rev 2:141–147
45. De Backer IC, Schep G, Backx FJ, Vreugdenhil G, Kuipers H (2009) Resistance training in cancer survivors: a systematic review. Int J Sports Med 30:703–712. doi:10.1055/s-0029-1225330
46. Weaver KE, Forsythe LP, Reeve BB, Alfano CM, Rodriguez JL, Sabatino SA, Hawkins NA, Rowland JH (2012) Mental and physical health-related quality of life among U.S. cancer survivors: population estimates from the 2010 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 21:2108–2117. doi:10.1158/1055-9965.EPI-12-0740
47. Silver JK, Baima J, Mayer RS (2013) Impairment-driven cancer rehabilitation: an essential component of quality care and survivorship. CA Cancer J Clin 63:295–317. doi:10.3322/caac.21186
48. Higano CS (2012) Sexuality and intimacy after definitive treatment and subsequent androgen deprivation therapy for prostate cancer. J Clin Oncol 30:3720–3725. doi:10.1200/JCO.2012.41.8509
49. Harrington JM, Schwenke DC, Epstein DR, Bailey DE Jr (2014) Androgen-deprivation therapy and metabolic syndrome in men with prostate cancer. Oncol Nurs Forum 41:21–29. doi:10.1188/14.ONF.21-29
50. Shahinian VB, Kou YF, Freeman JL, Orihuela E, Goodwin JS (2005) Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer 103:1615–1624
51. Bhasin S (2003) Testosterone supplementation for aging-associated sarcopenia. J Gerontol A Biol Sci Med Sci 58:1002–1008
52. Yuki A, Otsuka R, Kozakai R, Kitamura I, Okura T, Ando F, Shimokata H (2013) Relationship between low free testosterone levels and loss of muscle mass. Sci Rep 3:1818. doi:10.1038/srep01818
53. Nguyen PL, Alibhai SM, Basaria S, D’Amico AV, Kantoff PW, Keating NL, Penson DF, Rosario DJ, Tombal B, Smith MR (2014) Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. doi:10.1016/j.eururo.2014.07.010
54. Rowlands MA, Gunnel D, Harris R, Vatten LJ, Holly JM, Martin RM (2009) Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int J Cancer 124:2416–2429. doi:10.1002/ijc.24202
55. Hanson ED, Srivatsan SR, Agraval S, Menon KS, Delmonico MJ, Wang MQ, Hurley BF (2009) Effects of strength training on physical function: influence of power, strength, and body composition. J Strength Cond Res 23:2627–2637. doi:10.1519/JSC.0b013e3181b2297b
56. Holviala J, Kraemer WJ, Sillanpää E, Karppinen H, Avela J, Kauhanen A, Häkkinen A, Häkkinen K (2012) Effects of strength, endurance and combined training on muscle strength, walking speed and dynamic balance in aging men. Eur J Appl Physiol 112:1335–1347. doi:10.1007/s00421-011-2089-7
57. Snow CM, Shaw JM, Winters KM, Witzke KA (2000) Long-term exercise using weighted vests prevents hip bone loss in postmenopausal women. J Gerontol A Biol Sci Med Sci 55:M489–491
58. Winters-Stone KM, Dobek J, Nail LM, Bennet JA, Leo MC, Torgrimson-Ojerio B, Luoh SW, Schwartz A (2013) Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial. Osteoporos Int 24:1637–1646. doi:10.1007/s00198-012-2143-2
59. Shaw JM, Snow KM (1998) Weighted vest exercise improves indices of fall risk in older women. J Gerontol A Biol Sci Med Sci 53:M53–58
60. Carmack Taylor CL, Demoor C, Smith MA, Dunn AL, Basen-Enqquist K, Nielsen I, Pettaway C, Sellin R, Massey P, Gritz ER (2006) Active for life after cancer: a randomized trial examining a lifestyle physical activity program for prostate cancer patients. Psychooncology 15:847–862
61. Brown JK, Byers T, Doyle C, Courneya KS, Demark-Wahnefried W, Kushi LH, McTiernan A, Rock CL, Aziz N, Bloch AS, Eldridge B, Hamilton K, Katzin C, Koonce A, Main J, Mobley C, Morra ME, Pierce MS, Sawyer KA (2003) Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 53:268–291
62. Horn SD, DeJong G, Deutscher D (2012) Practice-based evidence research in rehabilitation: an alternative to randomized controlled trials and traditional observational studies. Arch Phys Med Rehabil 93(Suppl 2):127–37